Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Milestone ScientificMLSS -10.47%37 Median PS Value is $0.59 as of Aug. 16, 2026, which is 61% below its 10-year median of 1.50. GuruFocus rates MLSS with a GF Score™ of 37/100 and a GF Value™ of $0.60 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 336 Medical Devices & Instruments companies, Milestone Scientific ranks worse than 62.8% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Milestone Scientific's Median PS Value or its related term are showing as below:
MLSS'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.45 Med: 1.5 Max: 11.9
Current: 0.84
During the past 13 years, the highest Price to Median PS Value of Milestone Scientific was 11.90. The lowest was 0.45. And the median was 1.50.
MLSS's Price-to-Median-PS-Value is ranked worse than 62.8% of 336
companies
in the Medical Devices & Instruments industry
Industry Median: 0.715
vs MLSS: 0.84
Milestone Scientific (AMEX:MLSS) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Milestone Scientific's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.4951
/
0.59
=
0.84
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milestone Scientific Median PS Value Related Terms
Milestone Scientific Median PS Value Historical Data
* Premium members only.
The historical data trend for Milestone Scientific's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLSS vs NEPH, HBIO, POCI: Median PS Value Comparison
For the Medical Instruments & Supplies subindustry, Milestone Scientific's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Milestone Scientific Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Milestone Scientific's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 5.3636.
Milestone Scientific's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.11.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Milestone Scientific (MLSS) has a Median PS Value of $0.59 as of Aug. 16, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Milestone Scientific and its competitors. This is 61% below median its historical median of 1.50. Over the past decade, Milestone Scientific's Median PS Value has ranged from 0.45 to 11.90. According to the industry distribution chart, Milestone Scientific ranks #211 out of 336 companies in the Medical Devices & Instruments industry, placing it in the top 62.8%.
Is Milestone Scientific's Median PS Value too high?
Milestone Scientific's current Median PS Value of $0.59 is 61% below median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 11.90. The Medical Devices & Instruments industry median Median PS Value is 0.72. Milestone Scientific's value of $0.59 is 17.5% below this industry median. Based on the distribution chart, Milestone Scientific ranks #211 out of 336 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Milestone Scientific has a GF Score™ of 37/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Milestone Scientific's Median PS Value compare to NEPH and HBIO?
According to the Medical Devices & Instruments industry distribution chart, Milestone Scientific ranks #211 out of 336 companies for Median PS Value. This places Milestone Scientific in the lower half of its industry. The industry median Median PS Value is 0.72. Milestone Scientific's value of $0.59 is 17.5% below this benchmark. Historically, Milestone Scientific's own Median PS Value has ranged from 0.45 to 11.90 over the past decade. While the company's 10-year median is 1.50 vs. the industry median of 0.72, Milestone Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.72, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Milestone Scientific's current Median PS Value of $0.59 is 17.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Milestone Scientific and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Milestone Scientific's current Median PS Value is $0.59, which is 61% below median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milestone Scientific stock overvalued right now?
Based on GuruFocus' analysis, Milestone Scientific (MLSS) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.60, compared to a current price of $0.50 — trading 17.5% below its estimated fair value. The current Median PS Value is $0.59, which is 61% below median its 10-year median of 1.50 and 17.5% below the Medical Devices & Instruments industry median of 0.72. Milestone Scientific's overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Milestone Scientific (MLSS), the current Median PS Value is $0.59 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Milestone Scientific (MLSS) Overvalued in 2026?
Based on GuruFocus' analysis, Milestone Scientific stock appears to be undervalued.
The current stock price of $0.50 is trading 17.5% below its estimated GF Value™ of $0.60.
GuruFocus considers Milestone Scientific to be Modestly Undervalued.
Key valuation signals for MLSS:
Median PS Value: $0.59 (61% below median its 10-year median of 1.50)
GF Value™: $0.60 vs. price of $0.50 (17.5% below fair value)
Industry Position: 17.5% below the Medical Devices & Instruments median (#211 of 336)
No single metric tells the full story. See the MLSS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.
37GF Score
Get the complete analysis for MLSS
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLSS has been successfully added to your 
